

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | drug transmembrane transport (GO:0006855) | 6.21771920 |
| 2 | urate metabolic process (GO:0046415) | 6.09120050 |
| 3 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.64090213 |
| 4 | organic cation transport (GO:0015695) | 5.63132221 |
| 5 | drug transport (GO:0015893) | 5.32962871 |
| 6 | lysine metabolic process (GO:0006553) | 5.19076190 |
| 7 | lysine catabolic process (GO:0006554) | 5.19076190 |
| 8 | behavioral response to nicotine (GO:0035095) | 5.04124109 |
| 9 | phosphate ion transport (GO:0006817) | 4.78143120 |
| 10 | nonribosomal peptide biosynthetic process (GO:0019184) | 4.66274217 |
| 11 | excretion (GO:0007588) | 4.47034093 |
| 12 | cysteine metabolic process (GO:0006534) | 4.46441373 |
| 13 | fucose catabolic process (GO:0019317) | 4.33759878 |
| 14 | L-fucose metabolic process (GO:0042354) | 4.33759878 |
| 15 | L-fucose catabolic process (GO:0042355) | 4.33759878 |
| 16 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.32429583 |
| 17 | glutathione biosynthetic process (GO:0006750) | 4.30408141 |
| 18 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.21318717 |
| 19 | phosphate ion transmembrane transport (GO:0035435) | 4.13543113 |
| 20 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.13199997 |
| 21 | ATP synthesis coupled proton transport (GO:0015986) | 4.13199997 |
| 22 | tryptophan catabolic process (GO:0006569) | 4.07935083 |
| 23 | indole-containing compound catabolic process (GO:0042436) | 4.07935083 |
| 24 | indolalkylamine catabolic process (GO:0046218) | 4.07935083 |
| 25 | polyol transport (GO:0015791) | 4.06653266 |
| 26 | metanephric tubule development (GO:0072170) | 4.05002911 |
| 27 | metanephric nephron tubule development (GO:0072234) | 4.05002911 |
| 28 | aspartate family amino acid catabolic process (GO:0009068) | 3.97353668 |
| 29 | aromatic amino acid family catabolic process (GO:0009074) | 3.96412285 |
| 30 | short-chain fatty acid metabolic process (GO:0046459) | 3.96390236 |
| 31 | peptide biosynthetic process (GO:0043043) | 3.86596066 |
| 32 | regulation of hippo signaling (GO:0035330) | 3.85276109 |
| 33 | glyoxylate metabolic process (GO:0046487) | 3.84602976 |
| 34 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.83127386 |
| 35 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.83127386 |
| 36 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.83127386 |
| 37 | response to mercury ion (GO:0046689) | 3.78987782 |
| 38 | neuron cell-cell adhesion (GO:0007158) | 3.76288716 |
| 39 | tryptophan metabolic process (GO:0006568) | 3.65924804 |
| 40 | dopamine transport (GO:0015872) | 3.64307113 |
| 41 | metanephric nephron epithelium development (GO:0072243) | 3.64251237 |
| 42 | respiratory electron transport chain (GO:0022904) | 3.63895968 |
| 43 | dopamine biosynthetic process (GO:0042416) | 3.60655818 |
| 44 | axon ensheathment in central nervous system (GO:0032291) | 3.58515587 |
| 45 | central nervous system myelination (GO:0022010) | 3.58515587 |
| 46 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.57641938 |
| 47 | L-phenylalanine catabolic process (GO:0006559) | 3.57641938 |
| 48 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.56501142 |
| 49 | electron transport chain (GO:0022900) | 3.53608159 |
| 50 | response to phenylpropanoid (GO:0080184) | 3.53556424 |
| 51 | glutamate metabolic process (GO:0006536) | 3.53375340 |
| 52 | sulfation (GO:0051923) | 3.45990630 |
| 53 | quaternary ammonium group transport (GO:0015697) | 3.45616138 |
| 54 | renal absorption (GO:0070293) | 3.43069973 |
| 55 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.42776145 |
| 56 | L-phenylalanine metabolic process (GO:0006558) | 3.42776145 |
| 57 | DNA deamination (GO:0045006) | 3.42640644 |
| 58 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.40023527 |
| 59 | cellular ketone body metabolic process (GO:0046950) | 3.39903667 |
| 60 | metanephric epithelium development (GO:0072207) | 3.35520779 |
| 61 | interkinetic nuclear migration (GO:0022027) | 3.34631043 |
| 62 | indole-containing compound metabolic process (GO:0042430) | 3.31638258 |
| 63 | cellular biogenic amine catabolic process (GO:0042402) | 3.31405230 |
| 64 | amine catabolic process (GO:0009310) | 3.31405230 |
| 65 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 3.30403516 |
| 66 | regulation of gene silencing by RNA (GO:0060966) | 3.27577410 |
| 67 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.27577410 |
| 68 | regulation of gene silencing by miRNA (GO:0060964) | 3.27577410 |
| 69 | drug catabolic process (GO:0042737) | 3.20371011 |
| 70 | kynurenine metabolic process (GO:0070189) | 3.20349217 |
| 71 | vitamin D metabolic process (GO:0042359) | 3.19793456 |
| 72 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.13880051 |
| 73 | detection of light stimulus involved in visual perception (GO:0050908) | 3.13880051 |
| 74 | branched-chain amino acid metabolic process (GO:0009081) | 3.13370475 |
| 75 | proline metabolic process (GO:0006560) | 3.13216938 |
| 76 | presynaptic membrane assembly (GO:0097105) | 3.10973248 |
| 77 | modified amino acid transport (GO:0072337) | 3.10354984 |
| 78 | acetyl-CoA metabolic process (GO:0006084) | 3.10033284 |
| 79 | exogenous drug catabolic process (GO:0042738) | 3.07025441 |
| 80 | nephron tubule morphogenesis (GO:0072078) | 3.07011514 |
| 81 | nephron epithelium morphogenesis (GO:0072088) | 3.07011514 |
| 82 | oligosaccharide catabolic process (GO:0009313) | 3.06601986 |
| 83 | response to pheromone (GO:0019236) | 3.03737426 |
| 84 | aromatic amino acid family metabolic process (GO:0009072) | 3.03309211 |
| 85 | indolalkylamine metabolic process (GO:0006586) | 3.00565356 |
| 86 | NAD biosynthetic process (GO:0009435) | 2.98437393 |
| 87 | hydrogen ion transmembrane transport (GO:1902600) | 2.98036210 |
| 88 | neural tube formation (GO:0001841) | 2.97547002 |
| 89 | cAMP catabolic process (GO:0006198) | 2.96819746 |
| 90 | kidney morphogenesis (GO:0060993) | 2.96068429 |
| 91 | transepithelial transport (GO:0070633) | 2.96030592 |
| 92 | glutathione derivative biosynthetic process (GO:1901687) | 2.95005953 |
| 93 | glutathione derivative metabolic process (GO:1901685) | 2.95005953 |
| 94 | nephron tubule development (GO:0072080) | 2.94410985 |
| 95 | protein K11-linked deubiquitination (GO:0035871) | 2.94392849 |
| 96 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.93711537 |
| 97 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.93711537 |
| 98 | establishment of protein localization to Golgi (GO:0072600) | 2.93709452 |
| 99 | ketone body metabolic process (GO:1902224) | 2.93438958 |
| 100 | branched-chain amino acid catabolic process (GO:0009083) | 2.92610135 |
| 101 | neurotransmitter biosynthetic process (GO:0042136) | 2.91144419 |
| 102 | vocalization behavior (GO:0071625) | 2.90833732 |
| 103 | presynaptic membrane organization (GO:0097090) | 2.88731219 |
| 104 | trivalent inorganic anion homeostasis (GO:0072506) | 2.87408166 |
| 105 | phosphate ion homeostasis (GO:0055062) | 2.87408166 |
| 106 | sodium ion transport (GO:0006814) | 2.85663818 |
| 107 | chaperone-mediated protein transport (GO:0072321) | 2.85379151 |
| 108 | serine family amino acid catabolic process (GO:0009071) | 2.84845954 |
| 109 | homocysteine metabolic process (GO:0050667) | 2.84472646 |
| 110 | glycoside metabolic process (GO:0016137) | 2.84085083 |
| 111 | neuronal action potential (GO:0019228) | 2.82327878 |
| 112 | serine family amino acid metabolic process (GO:0009069) | 2.82088354 |
| 113 | regulation of establishment of cell polarity (GO:2000114) | 2.80819727 |
| 114 | toxin transport (GO:1901998) | 2.79584945 |
| 115 | primary amino compound metabolic process (GO:1901160) | 2.79384408 |
| 116 | glutathione metabolic process (GO:0006749) | 2.79232493 |
| 117 | aldehyde catabolic process (GO:0046185) | 2.78441602 |
| 118 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.78060797 |
| 119 | neuronal action potential propagation (GO:0019227) | 2.77923791 |
| 120 | positive regulation of fatty acid oxidation (GO:0046321) | 2.77763635 |
| 121 | axoneme assembly (GO:0035082) | 2.76609564 |
| 122 | cellular response to ammonium ion (GO:0071242) | 2.76266482 |
| 123 | cellular modified amino acid catabolic process (GO:0042219) | 2.75060267 |
| 124 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.74668865 |
| 125 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.74335671 |
| 126 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.72363215 |
| 127 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.72354409 |
| 128 | benzene-containing compound metabolic process (GO:0042537) | 2.72056207 |
| 129 | L-ascorbic acid metabolic process (GO:0019852) | 2.68643719 |
| 130 | rRNA catabolic process (GO:0016075) | 2.68624674 |
| 131 | cyclic nucleotide catabolic process (GO:0009214) | 2.68516138 |
| 132 | hydrogen transport (GO:0006818) | 2.68195105 |
| 133 | gamma-aminobutyric acid transport (GO:0015812) | 2.67917961 |
| 134 | oxidative demethylation (GO:0070989) | 2.67786079 |
| 135 | positive regulation of developmental pigmentation (GO:0048087) | 2.66997427 |
| 136 | reflex (GO:0060004) | 2.66560920 |
| 137 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.65961257 |
| 138 | proton transport (GO:0015992) | 2.65123018 |
| 139 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.62815150 |
| 140 | regulation of pigment cell differentiation (GO:0050932) | 2.61748464 |
| 141 | epithelial cilium movement (GO:0003351) | 2.61706713 |
| 142 | transferrin transport (GO:0033572) | 2.61464029 |
| 143 | regulation of action potential (GO:0098900) | 2.61166349 |
| 144 | regulation of memory T cell differentiation (GO:0043380) | 2.61118321 |
| 145 | cellular response to exogenous dsRNA (GO:0071360) | 2.59963966 |
| 146 | cellular amino acid catabolic process (GO:0009063) | 2.59716127 |
| 147 | alpha-amino acid catabolic process (GO:1901606) | 2.59153810 |
| 148 | reciprocal DNA recombination (GO:0035825) | 2.58769708 |
| 149 | reciprocal meiotic recombination (GO:0007131) | 2.58769708 |
| 150 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.57322044 |
| 151 | serotonin metabolic process (GO:0042428) | 2.57145476 |
| 152 | protein K48-linked deubiquitination (GO:0071108) | 2.56912959 |
| 153 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.56278015 |
| 154 | negative regulation of mast cell activation (GO:0033004) | 2.55301218 |
| 155 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.53322844 |
| 156 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.53322844 |
| 157 | peristalsis (GO:0030432) | 2.50370256 |
| 158 | piRNA metabolic process (GO:0034587) | 2.47391654 |
| 159 | positive regulation of mRNA catabolic process (GO:0061014) | 2.47288725 |
| 160 | behavioral response to ethanol (GO:0048149) | 2.46652754 |
| 161 | cilium movement (GO:0003341) | 2.46615415 |
| 162 | cellular response to ethanol (GO:0071361) | 2.46394433 |
| 163 | positive regulation of defense response to virus by host (GO:0002230) | 2.46293393 |
| 164 | renal tubule morphogenesis (GO:0061333) | 2.45001653 |
| 165 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.44214578 |
| 166 | regulation of hexokinase activity (GO:1903299) | 2.44104585 |
| 167 | regulation of glucokinase activity (GO:0033131) | 2.44104585 |
| 168 | thyroid hormone metabolic process (GO:0042403) | 2.43244018 |
| 169 | cellular response to ATP (GO:0071318) | 2.42982263 |
| 170 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.42918381 |
| 171 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.40810960 |
| 172 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.40274470 |
| 173 | auditory receptor cell stereocilium organization (GO:0060088) | 2.40057725 |
| 174 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.40002221 |
| 175 | protein K63-linked deubiquitination (GO:0070536) | 2.39544021 |
| 176 | regulation of mesoderm development (GO:2000380) | 2.38232080 |
| 177 | negative regulation of telomere maintenance (GO:0032205) | 2.37394422 |
| 178 | alanine transport (GO:0032328) | 2.36058861 |
| 179 | negative regulation of sodium ion transport (GO:0010766) | 2.34666269 |
| 180 | S-adenosylmethionine metabolic process (GO:0046500) | 2.34520212 |
| 181 | positive regulation of fatty acid transport (GO:2000193) | 2.34451512 |
| 182 | photoreceptor cell maintenance (GO:0045494) | 2.33331013 |
| 183 | cornea development in camera-type eye (GO:0061303) | 2.32867948 |
| 184 | spinal cord motor neuron differentiation (GO:0021522) | 2.32633357 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.01336244 |
| 2 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.55222206 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.50352478 |
| 4 | VDR_22108803_ChIP-Seq_LS180_Human | 3.08571962 |
| 5 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.58191038 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.52534593 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.50486312 |
| 8 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.48897382 |
| 9 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.45842960 |
| 10 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.41802798 |
| 11 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.38225279 |
| 12 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.26118377 |
| 13 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.24170292 |
| 14 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.19925142 |
| 15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.09279504 |
| 16 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.05683080 |
| 17 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.03952150 |
| 18 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.03442107 |
| 19 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.02637815 |
| 20 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.02506219 |
| 21 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.00636392 |
| 22 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.97186352 |
| 23 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.96770343 |
| 24 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.96770343 |
| 25 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.95774783 |
| 26 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.91828202 |
| 27 | EWS_26573619_Chip-Seq_HEK293_Human | 1.80659740 |
| 28 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.79348620 |
| 29 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.78208107 |
| 30 | STAT3_23295773_ChIP-Seq_U87_Human | 1.77137586 |
| 31 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.75427958 |
| 32 | P300_19829295_ChIP-Seq_ESCs_Human | 1.71924042 |
| 33 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.70240581 |
| 34 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.69720684 |
| 35 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.69600392 |
| 36 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.66713476 |
| 37 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.61581346 |
| 38 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.61354464 |
| 39 | TCF4_23295773_ChIP-Seq_U87_Human | 1.60002462 |
| 40 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.59935967 |
| 41 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.53756794 |
| 42 | FUS_26573619_Chip-Seq_HEK293_Human | 1.53334491 |
| 43 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.51838724 |
| 44 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.50834803 |
| 45 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.50352493 |
| 46 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.50352493 |
| 47 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.50042650 |
| 48 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.48953846 |
| 49 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.48246129 |
| 50 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.47042224 |
| 51 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.45181847 |
| 52 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.44552094 |
| 53 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.44076676 |
| 54 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.44076676 |
| 55 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.41668587 |
| 56 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.40746239 |
| 57 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.38988109 |
| 58 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.38829561 |
| 59 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.38271890 |
| 60 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.38239743 |
| 61 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.36097089 |
| 62 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.34449725 |
| 63 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.34418900 |
| 64 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.32763813 |
| 65 | TP53_16413492_ChIP-PET_HCT116_Human | 1.31935934 |
| 66 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.31825550 |
| 67 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.30962230 |
| 68 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.30353538 |
| 69 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.29969621 |
| 70 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.29949604 |
| 71 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.29843773 |
| 72 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.27836596 |
| 73 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.27765300 |
| 74 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.27507487 |
| 75 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.27197246 |
| 76 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.26221073 |
| 77 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.25293510 |
| 78 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.25173715 |
| 79 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.24888951 |
| 80 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.24379981 |
| 81 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.24300549 |
| 82 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.23234067 |
| 83 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.22785981 |
| 84 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.22599601 |
| 85 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.22409153 |
| 86 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.21261739 |
| 87 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.21061967 |
| 88 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.20762598 |
| 89 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.20523749 |
| 90 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.20496650 |
| 91 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.19367862 |
| 92 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.18498876 |
| 93 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.17893283 |
| 94 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.17250218 |
| 95 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.16934041 |
| 96 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.16934041 |
| 97 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.14776318 |
| 98 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.12893540 |
| 99 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.12206253 |
| 100 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.11815381 |
| 101 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.11382253 |
| 102 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.11064980 |
| 103 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.10444537 |
| 104 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.09954873 |
| 105 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.09634986 |
| 106 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.09581550 |
| 107 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.09536228 |
| 108 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.09464385 |
| 109 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.09313654 |
| 110 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.08865485 |
| 111 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.08559350 |
| 112 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.08133386 |
| 113 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.07447028 |
| 114 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.06727604 |
| 115 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.06575159 |
| 116 | AR_25329375_ChIP-Seq_VCAP_Human | 1.06265263 |
| 117 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.05733729 |
| 118 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.05515052 |
| 119 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.04848366 |
| 120 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.04579613 |
| 121 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.04160880 |
| 122 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.04129156 |
| 123 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.03881307 |
| 124 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.03835665 |
| 125 | RXR_22108803_ChIP-Seq_LS180_Human | 1.03014812 |
| 126 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.02165506 |
| 127 | AR_20517297_ChIP-Seq_VCAP_Human | 1.02037824 |
| 128 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.01885656 |
| 129 | JUN_21703547_ChIP-Seq_K562_Human | 1.01813931 |
| 130 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.00230341 |
| 131 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.00184766 |
| 132 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.99797988 |
| 133 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99588388 |
| 134 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.99304553 |
| 135 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.98647764 |
| 136 | KDM2B_26808549_Chip-Seq_REH_Human | 0.98548257 |
| 137 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.98344436 |
| 138 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.98344436 |
| 139 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.98035936 |
| 140 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.98031461 |
| 141 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.97999634 |
| 142 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.94686527 |
| 143 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.94389890 |
| 144 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.93297219 |
| 145 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.92020672 |
| 146 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.91784819 |
| 147 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.91757189 |
| 148 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.91650637 |
| 149 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.91506052 |
| 150 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.89470943 |
| 151 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.89368898 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 4.82372196 |
| 2 | MP0004043_abnormal_pH_regulation | 4.41197665 |
| 3 | MP0003880_abnormal_central_pattern | 3.74926832 |
| 4 | MP0000569_abnormal_digit_pigmentation | 3.53087017 |
| 5 | MP0005332_abnormal_amino_acid | 3.38739017 |
| 6 | MP0003646_muscle_fatigue | 3.37077267 |
| 7 | MP0003195_calcinosis | 3.25358719 |
| 8 | MP0004019_abnormal_vitamin_homeostasis | 3.20831352 |
| 9 | MP0002139_abnormal_hepatobiliary_system | 2.66581248 |
| 10 | MP0008877_abnormal_DNA_methylation | 2.65097271 |
| 11 | MP0004859_abnormal_synaptic_plasticity | 2.49990359 |
| 12 | MP0005423_abnormal_somatic_nervous | 2.37543189 |
| 13 | MP0001765_abnormal_ion_homeostasis | 2.31473264 |
| 14 | MP0009745_abnormal_behavioral_response | 2.24501541 |
| 15 | MP0003635_abnormal_synaptic_transmissio | 2.18389913 |
| 16 | MP0004270_analgesia | 2.13327277 |
| 17 | MP0002064_seizures | 2.12849199 |
| 18 | MP0008875_abnormal_xenobiotic_pharmacok | 2.07108309 |
| 19 | MP0002876_abnormal_thyroid_physiology | 2.05967356 |
| 20 | MP0009046_muscle_twitch | 2.02031333 |
| 21 | MP0004885_abnormal_endolymph | 2.00599976 |
| 22 | MP0009643_abnormal_urine_homeostasis | 1.99539074 |
| 23 | MP0002138_abnormal_hepatobiliary_system | 1.96216690 |
| 24 | MP0005377_hearing/vestibular/ear_phenot | 1.93417036 |
| 25 | MP0003878_abnormal_ear_physiology | 1.93417036 |
| 26 | MP0001486_abnormal_startle_reflex | 1.92881177 |
| 27 | MP0003787_abnormal_imprinting | 1.91802212 |
| 28 | MP0005636_abnormal_mineral_homeostasis | 1.90996771 |
| 29 | MP0001968_abnormal_touch/_nociception | 1.90768304 |
| 30 | MP0001905_abnormal_dopamine_level | 1.86445085 |
| 31 | MP0001529_abnormal_vocalization | 1.83990486 |
| 32 | MP0005174_abnormal_tail_pigmentation | 1.83501458 |
| 33 | MP0008057_abnormal_DNA_replication | 1.82899050 |
| 34 | MP0005645_abnormal_hypothalamus_physiol | 1.82839550 |
| 35 | MP0001756_abnormal_urination | 1.80893518 |
| 36 | MP0002837_dystrophic_cardiac_calcinosis | 1.80318299 |
| 37 | MP0002063_abnormal_learning/memory/cond | 1.79154411 |
| 38 | MP0002272_abnormal_nervous_system | 1.79133595 |
| 39 | MP0002572_abnormal_emotion/affect_behav | 1.75921898 |
| 40 | MP0000427_abnormal_hair_cycle | 1.75707572 |
| 41 | MP0004147_increased_porphyrin_level | 1.75237148 |
| 42 | MP0002638_abnormal_pupillary_reflex | 1.74787625 |
| 43 | MP0004742_abnormal_vestibular_system | 1.70744373 |
| 44 | MP0001440_abnormal_grooming_behavior | 1.70235440 |
| 45 | MP0002736_abnormal_nociception_after | 1.69623408 |
| 46 | MP0002734_abnormal_mechanical_nocicepti | 1.66843867 |
| 47 | MP0004145_abnormal_muscle_electrophysio | 1.66314650 |
| 48 | MP0004130_abnormal_muscle_cell | 1.65830886 |
| 49 | MP0003252_abnormal_bile_duct | 1.64442239 |
| 50 | MP0002735_abnormal_chemical_nociception | 1.64429706 |
| 51 | MP0006276_abnormal_autonomic_nervous | 1.62080164 |
| 52 | MP0005409_darkened_coat_color | 1.60703796 |
| 53 | MP0003136_yellow_coat_color | 1.60181205 |
| 54 | MP0002067_abnormal_sensory_capabilities | 1.58348301 |
| 55 | MP0004142_abnormal_muscle_tone | 1.55664156 |
| 56 | MP0010329_abnormal_lipoprotein_level | 1.53090377 |
| 57 | MP0003045_fibrosis | 1.52791217 |
| 58 | MP0000383_abnormal_hair_follicle | 1.52611968 |
| 59 | MP0001188_hyperpigmentation | 1.50399909 |
| 60 | MP0005167_abnormal_blood-brain_barrier | 1.49874515 |
| 61 | MP0000778_abnormal_nervous_system | 1.48100445 |
| 62 | MP0002136_abnormal_kidney_physiology | 1.42147789 |
| 63 | MP0002102_abnormal_ear_morphology | 1.39749974 |
| 64 | MP0005253_abnormal_eye_physiology | 1.38924014 |
| 65 | MP0001485_abnormal_pinna_reflex | 1.36212099 |
| 66 | MP0000538_abnormal_urinary_bladder | 1.33848044 |
| 67 | MP0005535_abnormal_body_temperature | 1.32618159 |
| 68 | MP0001501_abnormal_sleep_pattern | 1.32032607 |
| 69 | MP0000920_abnormal_myelination | 1.30706133 |
| 70 | MP0003329_amyloid_beta_deposits | 1.30490844 |
| 71 | MP0002822_catalepsy | 1.26176224 |
| 72 | MP0002928_abnormal_bile_duct | 1.25774742 |
| 73 | MP0008961_abnormal_basal_metabolism | 1.25020394 |
| 74 | MP0005085_abnormal_gallbladder_physiolo | 1.24461702 |
| 75 | MP0006072_abnormal_retinal_apoptosis | 1.21756000 |
| 76 | MP0009379_abnormal_foot_pigmentation | 1.21531152 |
| 77 | MP0001963_abnormal_hearing_physiology | 1.20443100 |
| 78 | MP0005389_reproductive_system_phenotype | 1.20371495 |
| 79 | MP0002160_abnormal_reproductive_system | 1.18058178 |
| 80 | MP0002938_white_spotting | 1.17981182 |
| 81 | MP0000631_abnormal_neuroendocrine_gland | 1.17933779 |
| 82 | MP0000372_irregular_coat_pigmentation | 1.16801266 |
| 83 | MP0001970_abnormal_pain_threshold | 1.15587820 |
| 84 | MP0005451_abnormal_body_composition | 1.14896305 |
| 85 | MP0003011_delayed_dark_adaptation | 1.08083759 |
| 86 | MP0003879_abnormal_hair_cell | 1.07616280 |
| 87 | MP0002733_abnormal_thermal_nociception | 1.07502748 |
| 88 | MP0004924_abnormal_behavior | 1.07485246 |
| 89 | MP0005386_behavior/neurological_phenoty | 1.07485246 |
| 90 | MP0002066_abnormal_motor_capabilities/c | 1.06667945 |
| 91 | MP0001986_abnormal_taste_sensitivity | 1.05830125 |
| 92 | MP0002557_abnormal_social/conspecific_i | 1.04737746 |
| 93 | MP0001919_abnormal_reproductive_system | 1.04362778 |
| 94 | MP0003890_abnormal_embryonic-extraembry | 1.04042721 |
| 95 | MP0005084_abnormal_gallbladder_morpholo | 1.03714195 |
| 96 | MP0005670_abnormal_white_adipose | 1.02637930 |
| 97 | MP0000566_synostosis | 1.02207592 |
| 98 | MP0005448_abnormal_energy_balance | 1.01847622 |
| 99 | MP0004215_abnormal_myocardial_fiber | 1.00635402 |
| 100 | MP0000026_abnormal_inner_ear | 0.99842494 |
| 101 | MP0005365_abnormal_bile_salt | 0.97907869 |
| 102 | MP0005646_abnormal_pituitary_gland | 0.97000999 |
| 103 | MP0008872_abnormal_physiological_respon | 0.96487042 |
| 104 | MP0002693_abnormal_pancreas_physiology | 0.95858063 |
| 105 | MP0006036_abnormal_mitochondrial_physio | 0.94772340 |
| 106 | MP0005075_abnormal_melanosome_morpholog | 0.94070818 |
| 107 | MP0006035_abnormal_mitochondrial_morpho | 0.93202237 |
| 108 | MP0002229_neurodegeneration | 0.92281149 |
| 109 | MP0002168_other_aberrant_phenotype | 0.91444034 |
| 110 | MP0010386_abnormal_urinary_bladder | 0.90775998 |
| 111 | MP0003186_abnormal_redox_activity | 0.90644581 |
| 112 | MP0000230_abnormal_systemic_arterial | 0.90453872 |
| 113 | MP0001661_extended_life_span | 0.90245285 |
| 114 | MP0005551_abnormal_eye_electrophysiolog | 0.89087372 |
| 115 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.88102643 |
| 116 | MP0005310_abnormal_salivary_gland | 0.87543870 |
| 117 | MP0002069_abnormal_eating/drinking_beha | 0.86576307 |
| 118 | MP0001984_abnormal_olfaction | 0.86154047 |
| 119 | MP0005410_abnormal_fertilization | 0.84958039 |
| 120 | MP0003950_abnormal_plasma_membrane | 0.84583549 |
| 121 | MP0005379_endocrine/exocrine_gland_phen | 0.84421175 |
| 122 | MP0003938_abnormal_ear_development | 0.84295460 |
| 123 | MP0001177_atelectasis | 0.83917661 |
| 124 | MP0006292_abnormal_olfactory_placode | 0.83414844 |
| 125 | MP0001764_abnormal_homeostasis | 0.82913346 |
| 126 | MP0001664_abnormal_digestion | 0.82648565 |
| 127 | MP0002882_abnormal_neuron_morphology | 0.82360405 |
| 128 | MP0001873_stomach_inflammation | 0.81963565 |
| 129 | MP0005171_absent_coat_pigmentation | 0.81360732 |
| 130 | MP0002184_abnormal_innervation | 0.80993270 |
| 131 | MP0001958_emphysema | 0.80643614 |
| 132 | MP0008775_abnormal_heart_ventricle | 0.80536278 |
| 133 | MP0002009_preneoplasia | 0.80208828 |
| 134 | MP0003690_abnormal_glial_cell | 0.78865566 |
| 135 | MP0002095_abnormal_skin_pigmentation | 0.78233565 |
| 136 | MP0004381_abnormal_hair_follicle | 0.77914542 |
| 137 | MP0003718_maternal_effect | 0.77885753 |
| 138 | MP0005195_abnormal_posterior_eye | 0.77010734 |
| 139 | MP0002653_abnormal_ependyma_morphology | 0.76772218 |
| 140 | MP0004133_heterotaxia | 0.76730319 |
| 141 | MP0003638_abnormal_response/metabolism_ | 0.74299323 |
| 142 | MP0002752_abnormal_somatic_nervous | 0.73791267 |
| 143 | MP0005266_abnormal_metabolism | 0.73683430 |
| 144 | MP0003137_abnormal_impulse_conducting | 0.72745985 |
| 145 | MP0003953_abnormal_hormone_level | 0.72590482 |
| 146 | MP0001324_abnormal_eye_pigmentation | 0.72409895 |
| 147 | MP0001666_abnormal_nutrient_absorption | 0.71607335 |
| 148 | MP0000470_abnormal_stomach_morphology | 0.71571601 |
| 149 | MP0000955_abnormal_spinal_cord | 0.71372242 |
| 150 | MP0003631_nervous_system_phenotype | 0.68347429 |
| 151 | MP0003806_abnormal_nucleotide_metabolis | 0.66850137 |
| 152 | MP0005395_other_phenotype | 0.62917412 |
| 153 | MP0003634_abnormal_glial_cell | 0.62912625 |
| 154 | MP0003633_abnormal_nervous_system | 0.62873510 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased circulating renin level (HP:0000848) | 6.88833870 |
| 2 | Hypomagnesemia (HP:0002917) | 6.69468335 |
| 3 | Metabolic alkalosis (HP:0200114) | 6.63128567 |
| 4 | Hypokalemic alkalosis (HP:0001949) | 6.03331647 |
| 5 | Hyperactive renin-angiotensin system (HP:0000841) | 5.65718193 |
| 6 | Abnormality of magnesium homeostasis (HP:0004921) | 5.55702314 |
| 7 | Polyuria (HP:0000103) | 5.37080584 |
| 8 | Gout (HP:0001997) | 5.12318675 |
| 9 | Abnormal urine output (HP:0012590) | 5.07247917 |
| 10 | Abnormality of chloride homeostasis (HP:0011422) | 4.92306457 |
| 11 | Abnormality of renal excretion (HP:0011036) | 4.70656611 |
| 12 | Pancreatic cysts (HP:0001737) | 4.63858669 |
| 13 | Polydipsia (HP:0001959) | 4.46975394 |
| 14 | Abnormal drinking behavior (HP:0030082) | 4.46975394 |
| 15 | Renal salt wasting (HP:0000127) | 4.29467391 |
| 16 | Hyperaldosteronism (HP:0000859) | 4.26350431 |
| 17 | Proximal tubulopathy (HP:0000114) | 4.22299379 |
| 18 | Tetany (HP:0001281) | 4.20324200 |
| 19 | Abnormality of renin-angiotensin system (HP:0000847) | 4.06790234 |
| 20 | Pancreatic fibrosis (HP:0100732) | 3.96221297 |
| 21 | Increased purine levels (HP:0004368) | 3.94222949 |
| 22 | Hyperuricemia (HP:0002149) | 3.94222949 |
| 23 | Hyperglycinuria (HP:0003108) | 3.92485630 |
| 24 | Alkalosis (HP:0001948) | 3.92416416 |
| 25 | Abnormality of midbrain morphology (HP:0002418) | 3.80735332 |
| 26 | Molar tooth sign on MRI (HP:0002419) | 3.80735332 |
| 27 | Abnormality of the renal cortex (HP:0011035) | 3.77393463 |
| 28 | Genetic anticipation (HP:0003743) | 3.75559174 |
| 29 | Congenital stationary night blindness (HP:0007642) | 3.72691336 |
| 30 | True hermaphroditism (HP:0010459) | 3.71153105 |
| 31 | Nephronophthisis (HP:0000090) | 3.59145871 |
| 32 | Abnormality of the renal medulla (HP:0100957) | 3.41336922 |
| 33 | Gaze-evoked nystagmus (HP:0000640) | 3.39471529 |
| 34 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.35962670 |
| 35 | Abnormality of glycine metabolism (HP:0010895) | 3.35962670 |
| 36 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.25954581 |
| 37 | Progressive cerebellar ataxia (HP:0002073) | 3.24448033 |
| 38 | Acute encephalopathy (HP:0006846) | 3.18170378 |
| 39 | Hyperventilation (HP:0002883) | 3.14853554 |
| 40 | Large for gestational age (HP:0001520) | 3.13927207 |
| 41 | Attenuation of retinal blood vessels (HP:0007843) | 3.04782778 |
| 42 | Delayed CNS myelination (HP:0002188) | 3.03366427 |
| 43 | Hyperphosphaturia (HP:0003109) | 2.99858633 |
| 44 | Chronic hepatic failure (HP:0100626) | 2.97380980 |
| 45 | Glycosuria (HP:0003076) | 2.96885490 |
| 46 | Abnormality of urine glucose concentration (HP:0011016) | 2.96885490 |
| 47 | Renal tubular acidosis (HP:0001947) | 2.96885393 |
| 48 | Ketoacidosis (HP:0001993) | 2.94517260 |
| 49 | Type II lissencephaly (HP:0007260) | 2.93386687 |
| 50 | Cystic liver disease (HP:0006706) | 2.92667011 |
| 51 | Abnormality of purine metabolism (HP:0004352) | 2.90778387 |
| 52 | Clumsiness (HP:0002312) | 2.85944714 |
| 53 | Protruding tongue (HP:0010808) | 2.83870518 |
| 54 | Abnormal urine phosphate concentration (HP:0012599) | 2.81616933 |
| 55 | Acute necrotizing encephalopathy (HP:0006965) | 2.81516926 |
| 56 | Hypercalciuria (HP:0002150) | 2.78548457 |
| 57 | Hypokalemia (HP:0002900) | 2.76214702 |
| 58 | Abnormality of renal resorption (HP:0011038) | 2.70858969 |
| 59 | Abolished electroretinogram (ERG) (HP:0000550) | 2.70855649 |
| 60 | Decreased circulating renin level (HP:0003351) | 2.65307190 |
| 61 | Abnormality of alanine metabolism (HP:0010916) | 2.63818909 |
| 62 | Hyperalaninemia (HP:0003348) | 2.63818909 |
| 63 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.63818909 |
| 64 | Focal motor seizures (HP:0011153) | 2.63557925 |
| 65 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.60851465 |
| 66 | Confusion (HP:0001289) | 2.58365853 |
| 67 | Inability to walk (HP:0002540) | 2.55666379 |
| 68 | Febrile seizures (HP:0002373) | 2.53098812 |
| 69 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.51889809 |
| 70 | Renal tubular dysfunction (HP:0000124) | 2.47941450 |
| 71 | Birth length less than 3rd percentile (HP:0003561) | 2.45155640 |
| 72 | Renal cortical cysts (HP:0000803) | 2.44705500 |
| 73 | Abnormality of the pons (HP:0007361) | 2.43830885 |
| 74 | Medial flaring of the eyebrow (HP:0010747) | 2.43642936 |
| 75 | Abnormality of potassium homeostasis (HP:0011042) | 2.40970067 |
| 76 | Ketosis (HP:0001946) | 2.40678801 |
| 77 | Myokymia (HP:0002411) | 2.40123466 |
| 78 | Progressive inability to walk (HP:0002505) | 2.39461625 |
| 79 | Congenital, generalized hypertrichosis (HP:0004540) | 2.38561225 |
| 80 | Furrowed tongue (HP:0000221) | 2.38518901 |
| 81 | Hyperglycinemia (HP:0002154) | 2.37282038 |
| 82 | Cerebral edema (HP:0002181) | 2.36072925 |
| 83 | Progressive macrocephaly (HP:0004481) | 2.36009685 |
| 84 | Stomach cancer (HP:0012126) | 2.34209106 |
| 85 | Mitochondrial inheritance (HP:0001427) | 2.32696356 |
| 86 | Generalized hypopigmentation of hair (HP:0011358) | 2.32267375 |
| 87 | Generalized aminoaciduria (HP:0002909) | 2.30959456 |
| 88 | Widely spaced teeth (HP:0000687) | 2.26984249 |
| 89 | Hypoplasia of the pons (HP:0012110) | 2.26028098 |
| 90 | Nephrocalcinosis (HP:0000121) | 2.24258084 |
| 91 | Broad-based gait (HP:0002136) | 2.23702460 |
| 92 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.23325467 |
| 93 | Abnormal eating behavior (HP:0100738) | 2.22409151 |
| 94 | Congenital hepatic fibrosis (HP:0002612) | 2.22187616 |
| 95 | Keratoconus (HP:0000563) | 2.18520933 |
| 96 | Increased corneal curvature (HP:0100692) | 2.18520933 |
| 97 | Lethargy (HP:0001254) | 2.17758344 |
| 98 | Decreased central vision (HP:0007663) | 2.16906485 |
| 99 | Rickets (HP:0002748) | 2.16134932 |
| 100 | Delayed epiphyseal ossification (HP:0002663) | 2.16019843 |
| 101 | Vomiting (HP:0002013) | 2.15926889 |
| 102 | Cerebellar dysplasia (HP:0007033) | 2.14603321 |
| 103 | Abnormality of sodium homeostasis (HP:0010931) | 2.12534875 |
| 104 | Abnormality of nucleobase metabolism (HP:0010932) | 2.11076728 |
| 105 | Patellar aplasia (HP:0006443) | 2.10443764 |
| 106 | Hypothermia (HP:0002045) | 2.09223951 |
| 107 | Lissencephaly (HP:0001339) | 2.08403792 |
| 108 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.07765298 |
| 109 | Absent/shortened dynein arms (HP:0200106) | 2.07765298 |
| 110 | Hypophosphatemic rickets (HP:0004912) | 2.07154149 |
| 111 | Facial shape deformation (HP:0011334) | 2.06724557 |
| 112 | Potter facies (HP:0002009) | 2.06724557 |
| 113 | Hyponatremia (HP:0002902) | 2.05250998 |
| 114 | Hepatocellular necrosis (HP:0001404) | 2.01529334 |
| 115 | Increased CSF lactate (HP:0002490) | 2.00699629 |
| 116 | Bile duct proliferation (HP:0001408) | 2.00473665 |
| 117 | Abnormal biliary tract physiology (HP:0012439) | 2.00473665 |
| 118 | Fetal akinesia sequence (HP:0001989) | 1.99943525 |
| 119 | Methylmalonic aciduria (HP:0012120) | 1.99691084 |
| 120 | Pendular nystagmus (HP:0012043) | 1.98738480 |
| 121 | Dehydration (HP:0001944) | 1.98303346 |
| 122 | Sclerocornea (HP:0000647) | 1.97524824 |
| 123 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.96611796 |
| 124 | Hypophosphatemia (HP:0002148) | 1.95639361 |
| 125 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.95077869 |
| 126 | 3-Methylglutaconic aciduria (HP:0003535) | 1.93608227 |
| 127 | Renal Fanconi syndrome (HP:0001994) | 1.92801525 |
| 128 | Male pseudohermaphroditism (HP:0000037) | 1.92509918 |
| 129 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.91277435 |
| 130 | Polyphagia (HP:0002591) | 1.90895558 |
| 131 | Abnormality of the renal collecting system (HP:0004742) | 1.90418201 |
| 132 | Metabolic acidosis (HP:0001942) | 1.88664928 |
| 133 | Nephrolithiasis (HP:0000787) | 1.88356007 |
| 134 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.87570425 |
| 135 | Chorioretinal atrophy (HP:0000533) | 1.85724101 |
| 136 | Widely patent fontanelles and sutures (HP:0004492) | 1.85552956 |
| 137 | Hemiparesis (HP:0001269) | 1.85384108 |
| 138 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.85315929 |
| 139 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.84239735 |
| 140 | Enlarged kidneys (HP:0000105) | 1.84133158 |
| 141 | Duplicated collecting system (HP:0000081) | 1.83763597 |
| 142 | Absent speech (HP:0001344) | 1.83072966 |
| 143 | Bulbous nose (HP:0000414) | 1.82763593 |
| 144 | Anencephaly (HP:0002323) | 1.81442172 |
| 145 | Hepatic necrosis (HP:0002605) | 1.80899718 |
| 146 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.80259548 |
| 147 | Thyroiditis (HP:0100646) | 1.79613597 |
| 148 | Increased serum pyruvate (HP:0003542) | 1.78781665 |
| 149 | Abnormality of glycolysis (HP:0004366) | 1.78781665 |
| 150 | Abnormality of the nasal septum (HP:0000419) | 1.78643642 |
| 151 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.78084768 |
| 152 | Dialeptic seizures (HP:0011146) | 1.77794752 |
| 153 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.77679381 |
| 154 | Leukodystrophy (HP:0002415) | 1.76845862 |
| 155 | Clubbing of toes (HP:0100760) | 1.76828839 |
| 156 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.75853739 |
| 157 | Hypoplastic iliac wings (HP:0002866) | 1.75574058 |
| 158 | Severe muscular hypotonia (HP:0006829) | 1.73603307 |
| 159 | Lactic acidosis (HP:0003128) | 1.73246239 |
| 160 | Tubular atrophy (HP:0000092) | 1.72880332 |
| 161 | Dicarboxylic aciduria (HP:0003215) | 1.72352169 |
| 162 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.72352169 |
| 163 | Gait imbalance (HP:0002141) | 1.71869728 |
| 164 | Concave nail (HP:0001598) | 1.69735055 |
| 165 | Adrenal overactivity (HP:0002717) | 1.68832343 |
| 166 | Optic disc pallor (HP:0000543) | 1.67631797 |
| 167 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.66237087 |
| 168 | Epileptic encephalopathy (HP:0200134) | 1.65588517 |
| 169 | Congenital sensorineural hearing impairment (HP:0008527) | 1.65506463 |
| 170 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.65249265 |
| 171 | Vascular calcification (HP:0004934) | 1.65206513 |
| 172 | Amelogenesis imperfecta (HP:0000705) | 1.65089996 |
| 173 | Congenital primary aphakia (HP:0007707) | 1.64035563 |
| 174 | Postaxial foot polydactyly (HP:0001830) | 1.63428849 |
| 175 | Partial agenesis of the corpus callosum (HP:0001338) | 1.63250314 |
| 176 | Tachypnea (HP:0002789) | 1.61464178 |
| 177 | Fair hair (HP:0002286) | 1.61002131 |
| 178 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.60976600 |
| 179 | Parakeratosis (HP:0001036) | 1.59947986 |
| 180 | Hypoplastic ischia (HP:0003175) | 1.59586065 |
| 181 | Limb dystonia (HP:0002451) | 1.59410886 |
| 182 | Focal seizures (HP:0007359) | 1.58863832 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 7.10442764 |
| 2 | WNK3 | 6.07985718 |
| 3 | OXSR1 | 5.83830518 |
| 4 | WNK4 | 4.70943217 |
| 5 | STK39 | 3.49086057 |
| 6 | ACVR1B | 3.46604257 |
| 7 | EPHA4 | 2.77650875 |
| 8 | CASK | 2.67041841 |
| 9 | MARK1 | 2.55068377 |
| 10 | PNCK | 2.41400166 |
| 11 | TAOK3 | 2.39502041 |
| 12 | ZAK | 2.08262794 |
| 13 | STK16 | 1.99899461 |
| 14 | NUAK1 | 1.82547888 |
| 15 | NTRK3 | 1.76343904 |
| 16 | TLK1 | 1.73402344 |
| 17 | IRAK2 | 1.69463550 |
| 18 | CAMKK2 | 1.67746887 |
| 19 | MAP4K2 | 1.66031203 |
| 20 | IRAK3 | 1.60126425 |
| 21 | TNIK | 1.52896306 |
| 22 | MAP2K7 | 1.52566999 |
| 23 | TXK | 1.50744367 |
| 24 | SGK223 | 1.48201212 |
| 25 | SGK494 | 1.48201212 |
| 26 | MAP3K4 | 1.42042212 |
| 27 | NME1 | 1.41807712 |
| 28 | PINK1 | 1.40782271 |
| 29 | MKNK2 | 1.39973908 |
| 30 | PIK3CA | 1.36718905 |
| 31 | STK38L | 1.34985015 |
| 32 | CAMK1D | 1.34664829 |
| 33 | MAP3K12 | 1.31607778 |
| 34 | MST4 | 1.31410272 |
| 35 | NLK | 1.27548000 |
| 36 | WNK1 | 1.21465323 |
| 37 | OBSCN | 1.20453469 |
| 38 | MAPKAPK3 | 1.17349759 |
| 39 | RIPK4 | 1.16756937 |
| 40 | BMPR2 | 1.15407308 |
| 41 | MINK1 | 1.13994213 |
| 42 | TGFBR1 | 1.10061963 |
| 43 | CAMK2B | 1.07238560 |
| 44 | TRPM7 | 1.06264616 |
| 45 | NEK6 | 1.06153519 |
| 46 | CDK19 | 1.04827953 |
| 47 | CAMK1G | 1.04327546 |
| 48 | TEC | 1.03097714 |
| 49 | BCKDK | 1.00908341 |
| 50 | MAP2K6 | 0.99697292 |
| 51 | GRK5 | 0.99411297 |
| 52 | BRSK2 | 0.98843537 |
| 53 | ARAF | 0.98661384 |
| 54 | IRAK1 | 0.98515722 |
| 55 | NTRK1 | 0.98244074 |
| 56 | MAPK13 | 0.97634473 |
| 57 | FGFR2 | 0.95981179 |
| 58 | PLK2 | 0.93089379 |
| 59 | PRKAA2 | 0.89575661 |
| 60 | PBK | 0.86877536 |
| 61 | MAP2K4 | 0.86689748 |
| 62 | PKN1 | 0.86347627 |
| 63 | NTRK2 | 0.84347086 |
| 64 | CAMK2A | 0.84239184 |
| 65 | DAPK2 | 0.82816140 |
| 66 | ADRBK2 | 0.81429027 |
| 67 | PIK3CG | 0.81025556 |
| 68 | STK38 | 0.80289958 |
| 69 | PHKG1 | 0.79387229 |
| 70 | PHKG2 | 0.79387229 |
| 71 | BCR | 0.78705696 |
| 72 | MAP3K7 | 0.78254152 |
| 73 | TNK2 | 0.77822263 |
| 74 | FES | 0.76748209 |
| 75 | PRKCG | 0.76597141 |
| 76 | ABL2 | 0.76294957 |
| 77 | SGK2 | 0.72636909 |
| 78 | CHUK | 0.72347985 |
| 79 | FGR | 0.72126010 |
| 80 | CDK5 | 0.70752821 |
| 81 | MAP3K9 | 0.69763673 |
| 82 | CAMK1 | 0.68465205 |
| 83 | PRPF4B | 0.68065359 |
| 84 | IKBKB | 0.67903942 |
| 85 | ITK | 0.65468080 |
| 86 | PRKCQ | 0.64711844 |
| 87 | PDK2 | 0.62989681 |
| 88 | UHMK1 | 0.61537726 |
| 89 | IRAK4 | 0.61129945 |
| 90 | SGK1 | 0.60715256 |
| 91 | CAMK2G | 0.60314207 |
| 92 | PRKAA1 | 0.58591618 |
| 93 | TIE1 | 0.58105946 |
| 94 | KIT | 0.58070775 |
| 95 | CAMK2D | 0.57836400 |
| 96 | CSNK1G2 | 0.57696563 |
| 97 | GRK7 | 0.57454666 |
| 98 | CSNK1G3 | 0.56451736 |
| 99 | PRKCE | 0.55952428 |
| 100 | ROCK2 | 0.55665406 |
| 101 | MELK | 0.54450229 |
| 102 | MAPKAPK5 | 0.54305514 |
| 103 | PRKCI | 0.53980840 |
| 104 | ERBB2 | 0.53111148 |
| 105 | SYK | 0.52379089 |
| 106 | DYRK2 | 0.51224473 |
| 107 | CAMKK1 | 0.50732632 |
| 108 | BRAF | 0.49837928 |
| 109 | PTK2B | 0.48850907 |
| 110 | BMPR1B | 0.48762652 |
| 111 | MAPK15 | 0.48227139 |
| 112 | PDK4 | 0.47430012 |
| 113 | PDK3 | 0.47430012 |
| 114 | AKT3 | 0.47299937 |
| 115 | PRKCZ | 0.46994028 |
| 116 | CAMK4 | 0.46561843 |
| 117 | STK3 | 0.45181189 |
| 118 | GRK6 | 0.45100613 |
| 119 | MAP2K1 | 0.43597721 |
| 120 | PRKACA | 0.43530237 |
| 121 | RPS6KA5 | 0.43186809 |
| 122 | ERBB4 | 0.43165286 |
| 123 | DYRK1A | 0.42913507 |
| 124 | VRK1 | 0.42735813 |
| 125 | CSNK1G1 | 0.42273893 |
| 126 | FGFR3 | 0.41292335 |
| 127 | STK11 | 0.41248355 |
| 128 | GRK1 | 0.40735739 |
| 129 | PAK3 | 0.40711888 |
| 130 | EPHA3 | 0.39590423 |
| 131 | MUSK | 0.39419372 |
| 132 | FER | 0.39288591 |
| 133 | PAK6 | 0.39177561 |
| 134 | IKBKE | 0.37607576 |
| 135 | MARK3 | 0.37598684 |
| 136 | MAPK11 | 0.37522709 |
| 137 | CDK14 | 0.37477547 |
| 138 | CDK3 | 0.36171598 |
| 139 | CDK15 | 0.35831021 |
| 140 | ADRBK1 | 0.35746341 |
| 141 | CDK18 | 0.35622977 |
| 142 | LATS1 | 0.35549241 |
| 143 | DAPK1 | 0.34889879 |
| 144 | CSNK1D | 0.34487392 |
| 145 | INSRR | 0.33229620 |
| 146 | PRKG1 | 0.33073070 |
| 147 | PDPK1 | 0.32282306 |
| 148 | PRKCA | 0.31861266 |
| 149 | NEK2 | 0.31833912 |
| 150 | CDK11A | 0.31175217 |
| 151 | PRKD2 | 0.30030032 |
| 152 | RPS6KA6 | 0.29879264 |
| 153 | FLT3 | 0.29576408 |
| 154 | LCK | 0.28813542 |
| 155 | MST1R | 0.28628131 |
| 156 | CDC42BPA | 0.28478510 |
| 157 | PLK4 | 0.28477563 |
| 158 | SGK3 | 0.28190977 |
| 159 | BTK | 0.27586200 |
| 160 | SIK2 | 0.27512868 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 4.01859546 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.30681091 |
| 3 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.25402810 |
| 4 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.03602759 |
| 5 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.79530025 |
| 6 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.65011598 |
| 7 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.58068804 |
| 8 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.51991192 |
| 9 | Parkinsons disease_Homo sapiens_hsa05012 | 2.45212308 |
| 10 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.43517845 |
| 11 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.39526049 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.27831090 |
| 13 | ABC transporters_Homo sapiens_hsa02010 | 2.26004560 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.25813926 |
| 15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.25364450 |
| 16 | Nicotine addiction_Homo sapiens_hsa05033 | 2.03865896 |
| 17 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.00367244 |
| 18 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.94295594 |
| 19 | Alzheimers disease_Homo sapiens_hsa05010 | 1.89823255 |
| 20 | * Peroxisome_Homo sapiens_hsa04146 | 1.80620154 |
| 21 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.77508234 |
| 22 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.77396307 |
| 23 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.73259276 |
| 24 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.70004308 |
| 25 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.68774411 |
| 26 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.65301010 |
| 27 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.63117193 |
| 28 | Huntingtons disease_Homo sapiens_hsa05016 | 1.61963303 |
| 29 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.61603083 |
| 30 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.58885725 |
| 31 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.57928380 |
| 32 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.54025097 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.54005099 |
| 34 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.53674256 |
| 35 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.49651175 |
| 36 | Homologous recombination_Homo sapiens_hsa03440 | 1.44468625 |
| 37 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.36871971 |
| 38 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.33761261 |
| 39 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.32213890 |
| 40 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.29650601 |
| 41 | Bile secretion_Homo sapiens_hsa04976 | 1.25124972 |
| 42 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.24495576 |
| 43 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.24419887 |
| 44 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.20457058 |
| 45 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.18810421 |
| 46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.18416487 |
| 47 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.17042498 |
| 48 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.17017365 |
| 49 | GABAergic synapse_Homo sapiens_hsa04727 | 1.15968302 |
| 50 | Circadian rhythm_Homo sapiens_hsa04710 | 1.10021837 |
| 51 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.08803109 |
| 52 | RNA polymerase_Homo sapiens_hsa03020 | 1.07347605 |
| 53 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.05974452 |
| 54 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.03627996 |
| 55 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.02817137 |
| 56 | Histidine metabolism_Homo sapiens_hsa00340 | 1.02807674 |
| 57 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.02528430 |
| 58 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.01875477 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 1.01344390 |
| 60 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.00952629 |
| 61 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.99741018 |
| 62 | Mineral absorption_Homo sapiens_hsa04978 | 0.98545469 |
| 63 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.97620357 |
| 64 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.97417957 |
| 65 | Taste transduction_Homo sapiens_hsa04742 | 0.96374697 |
| 66 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.95491994 |
| 67 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.91125366 |
| 68 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.90461303 |
| 69 | Basal transcription factors_Homo sapiens_hsa03022 | 0.89099364 |
| 70 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.88487332 |
| 71 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.87737622 |
| 72 | Morphine addiction_Homo sapiens_hsa05032 | 0.87460400 |
| 73 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.87338822 |
| 74 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.86834502 |
| 75 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.84965521 |
| 76 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.84099309 |
| 77 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.81800674 |
| 78 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.81239560 |
| 79 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.80871683 |
| 80 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.80857751 |
| 81 | Metabolic pathways_Homo sapiens_hsa01100 | 0.79305161 |
| 82 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.78394196 |
| 83 | Phototransduction_Homo sapiens_hsa04744 | 0.78100636 |
| 84 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.76601326 |
| 85 | RNA degradation_Homo sapiens_hsa03018 | 0.76088015 |
| 86 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.73419455 |
| 87 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.72997733 |
| 88 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.72769625 |
| 89 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.72282525 |
| 90 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.71722878 |
| 91 | Carbon metabolism_Homo sapiens_hsa01200 | 0.70495476 |
| 92 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.69284233 |
| 93 | Salivary secretion_Homo sapiens_hsa04970 | 0.69001805 |
| 94 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.68654871 |
| 95 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.67998916 |
| 96 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.66455328 |
| 97 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.66158624 |
| 98 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.64212042 |
| 99 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.61867426 |
| 100 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.60616360 |
| 101 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.60250046 |
| 102 | Circadian entrainment_Homo sapiens_hsa04713 | 0.60176169 |
| 103 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.59234839 |
| 104 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.58925343 |
| 105 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.58788754 |
| 106 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.58295096 |
| 107 | Long-term potentiation_Homo sapiens_hsa04720 | 0.57567315 |
| 108 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.57564464 |
| 109 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.57039996 |
| 110 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.56629374 |
| 111 | Asthma_Homo sapiens_hsa05310 | 0.54035805 |
| 112 | Cocaine addiction_Homo sapiens_hsa05030 | 0.53754853 |
| 113 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.53209259 |
| 114 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.53185032 |
| 115 | Other glycan degradation_Homo sapiens_hsa00511 | 0.51093933 |
| 116 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.51004268 |
| 117 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.50094448 |
| 118 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.49899638 |
| 119 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.48275257 |
| 120 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.47381417 |
| 121 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.45813734 |
| 122 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.45786374 |
| 123 | Long-term depression_Homo sapiens_hsa04730 | 0.45643538 |
| 124 | Renin secretion_Homo sapiens_hsa04924 | 0.45073243 |
| 125 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.44883381 |
| 126 | Retinol metabolism_Homo sapiens_hsa00830 | 0.44113971 |
| 127 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.42849355 |
| 128 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.42579791 |
| 129 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.40404118 |
| 130 | Insulin resistance_Homo sapiens_hsa04931 | 0.39623487 |
| 131 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.39600080 |
| 132 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.39438987 |
| 133 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.39429110 |
| 134 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.39335288 |
| 135 | Insulin secretion_Homo sapiens_hsa04911 | 0.38931580 |
| 136 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.38589839 |
| 137 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.38370230 |
| 138 | Olfactory transduction_Homo sapiens_hsa04740 | 0.38159044 |
| 139 | Protein export_Homo sapiens_hsa03060 | 0.37444191 |
| 140 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.37358773 |
| 141 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.34848347 |
| 142 | Axon guidance_Homo sapiens_hsa04360 | 0.34045580 |
| 143 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.33779188 |
| 144 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.33557133 |
| 145 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.31257661 |
| 146 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.30508607 |

